Auro Laboratories (BOM:530233) Cyclically Adjusted Book per Share: ₹51.91 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530233 Auro Laboratories Ltd BOM:530233
57 GF Score
Price ₹234.75
GF Value ₹152.37
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Auro Laboratories Cyclically Adjusted Book per Share?

Auro Laboratories BOM:530233 +1.16% 57 Cyclically Adjusted Book per Share is ₹51.91 as of Mar. 2026. GuruFocus rates BOM:530233 with a GF Score™ of 57/100 and a GF Value™ of ₹152.37 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Auro Laboratories's adjusted book value per share for the three months ended in Mar. 2026 was ₹74.358. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹51.91 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Auro Laboratories's average Cyclically Adjusted Book Growth Rate was 15.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 17.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 18.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Auro Laboratories was 19.20% per year. The lowest was 17.40% per year. And the median was 18.40% per year.

As of today (2026-08-08), Auro Laboratories's current stock price is ₹234.75. Auro Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₹51.91. Auro Laboratories's Cyclically Adjusted PB Ratio of today is 4.52.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Auro Laboratories was 7.20. The lowest was 1.71. And the median was 4.64.


Auro Laboratories  (BOM:530233) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Auro Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=234.75/51.91
=4.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Auro Laboratories was 7.20. The lowest was 1.71. And the median was 4.64.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Auro Laboratories Cyclically Adjusted Book per Share Related Terms


Auro Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Auro Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Auro Laboratories Cyclically Adjusted Book per Share Chart

Auro Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.06 32.04 38.73 44.87 51.91

Auro Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.87 0.00 48.70 0.00 51.91

BOM:530233 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Auro Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Auro Laboratories Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Auro Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Auro Laboratories's Cyclically Adjusted PB Ratio falls into.


BOM:530233
57GF Score
Auro Laboratories Ltd BOM:530233
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Auro Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Auro Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=74.358/164.2724*164.2724
=74.358

Current CPI (Mar. 2026) = 164.2724.

Auro Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 105.961 0.000
201609 14.924 105.961 23.137
201612 0.000 105.196 0.000
201703 15.102 105.196 23.583
201706 0.000 107.109 0.000
201709 18.230 109.021 27.469
201712 0.000 109.404 0.000
201803 20.821 109.786 31.154
201806 0.000 111.317 0.000
201809 23.397 115.142 33.380
201812 0.000 115.142 0.000
201903 27.935 118.202 38.823
201906 0.000 120.880 0.000
201909 32.086 123.175 42.792
201912 0.000 126.235 0.000
202003 34.490 124.705 45.433
202006 0.000 127.000 0.000
202009 40.312 130.118 50.893
202012 0.000 130.889 0.000
202103 45.857 131.771 57.168
202106 0.000 134.084 0.000
202109 48.617 135.847 58.790
202112 0.000 138.161 0.000
202203 50.571 138.822 59.842
202206 0.000 142.347 0.000
202209 51.256 144.661 58.205
202212 0.000 145.763 0.000
202303 54.870 146.865 61.374
202306 0.000 150.280 0.000
202309 59.380 151.492 64.390
202312 0.000 152.924 0.000
202403 67.332 153.035 72.276
202406 0.000 155.789 0.000
202409 69.577 157.882 72.393
202412 0.000 158.323 0.000
202503 68.936 157.552 71.877
202506 0.000 159.755 0.000
202509 69.916 162.289 70.770
202512 0.000 163.281 0.000
202603 74.358 164.272 74.358

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹51.91 mean?
Auro Laboratories (BOM:530233) has a Cyclically Adjusted Book per Share of ₹51.91 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Auro Laboratories and its competitors.
Is Auro Laboratories' Cyclically Adjusted Book per Share too high?
Auro Laboratories' current Cyclically Adjusted Book per Share is ₹51.91. Overall, Auro Laboratories has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Auro Laboratories' Cyclically Adjusted Book per Share compare to ZTS?
Auro Laboratories' Cyclically Adjusted Book per Share of ₹51.91 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Auro Laboratories and its competitors. Auro Laboratories's current Cyclically Adjusted Book per Share is ₹51.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Auro Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Auro Laboratories (BOM:530233) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹152.37, compared to a current price of ₹234.75 — trading 54.1% above its estimated fair value. The current Cyclically Adjusted Book per Share is ₹51.91. Auro Laboratories' overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Auro Laboratories (BOM:530233), the current Cyclically Adjusted Book per Share is ₹51.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Auro Laboratories (BOM:530233) Overvalued in 2026?

Based on GuruFocus' analysis, Auro Laboratories stock appears to be overvalued. The current stock price of ₹234.75 is trading 54.1% above its estimated GF Value™ of ₹152.37. GuruFocus considers Auro Laboratories to be Significantly Overvalued.

Key valuation signals for BOM:530233:

  • Cyclically Adjusted Book per Share: ₹51.91
  • GF Value™: ₹152.37 vs. price of ₹234.75 (54.1% above fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the BOM:530233 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Auro Laboratories Business Description

Address S.K. Ahire Marg, 314, 3rd Floor, T.V. Industrial Estate, Worli, Mumbai, MH, IND, 400 030
Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.
57GF Score

Get the complete analysis for BOM:530233

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹234.75
Price
₹152.37
GF Value